Fierce Competition Podcast | Antitrust Challenges in Organized Sports: How They Play Out in the EU, UK and US
Nota Bene Episode 136: Africa Q3 Check In: Diligent Competition Investigations and the Digitization of the Economy with Andreas Stargard
Healthcare Antitrust Enforcement Outlook with Former DOJ Antitrust Prosecutor and Strike Force District Leader
Compliance Perspectives: The Antitrust Division’s Office of Decree Enforcement
JONES DAY TALKS®: Private Antitrust Litigation in Europe: The Big Picture
FCPA Compliance Report-Episode 440, Jesse Caplan on the DOJ Evaluation of Corporate Compliance Programs for Antitrust
Antitrust Enforcement and Compliance Programs
Polsinelli Podcast - Keep the Government out of Your Transaction: Practical Antitrust Tips for Mergers
To date, 2024 has not yet seen the type of mega-merger (Pfizer/Seagen) or level of agency enforcement (Sanofi/Maze or Amgen/Horizon) as 2023. But two notable investigations — one still active — show the Federal Trade...more
The European Commission (EC) and other national competition authorities (NCAs) have traditionally shied away from investigating allegations of excessive pricing and appearing as price regulators. Commissioner Vestager warned...more
The UK Competition and Markets Authority (“CMA”) recently published its infringement decision of 7 December 2016 that imposed a fine on Pfizer and Flynn Pharma (“Flynn”) for abusing their respective dominant positions by...more